Human recombinant integrin alpha 4 beta 7 (from HEK293)
Catalog # ACRBIT7-H52W4-1MG
Supplier: ACRO Biosystems
CAS Number:
Some Products May Appear Restricted
To ensure a smooth and speedy checkout, please log in to your account. Some items may show as restricted simply because you're not logged in.
If you do not have an account, you can register using our registration webform (https://www.avantorsciences.com/us/en/login/register)
If you're still seeing restrictions after logging in, certain products—like chemicals or medical devices—require additional account verification steps to be able to place an order. Some items may additionally require a specific license or customer documentation; additional documentation will be requested for these items prior to shipment.
Specifications
- 包装规格:1 mg
- 结合:Unconjugated
- Protein/peptide type:Recombinant
- Source:HEK293 cells
- Species:Human
- 顺序:02
- 存储条件:–20 °C
- 内毒素含量:Less than 1,0 EU per μg by the LAL method.
- 生物活性:Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation. Measured by its binding ability in a functional ELISA. Immobilised Natalizumab at 1 μg/ml (100 μl/well) can bind Human ITGA4 and ITGB7 Heterodimer Protein, His Tag and Tag Free (Cat. No. ACRBIT7-H52W4) with a linear range of 4 - 63 ng/ml (QC tested).
- 基因:P13612-1 (ITGA4) and P26010-1 (ITGB7)
- Carrier-free:Y
- Protease-free:Y
- Animal-free:Y
- Protein synonyms:ITGA4&ITGB7|Integrin alpha 4 beta 7
- Protein/peptide name:Integrin alpha 4 beta 7
- 纯度:>90%
- 分子量:111,4 kDa (ITGA4) and 81,8 kDa (ITGB7)
- 内毒素水平:Low
- 配制:Lyophilised from 0,22 μm filtered solution in 50 mM Tris, 100 mM NaCl, pH 7,5. Normally trehalose is added as protectant before lyophilisation.
- 无核酸酶:Y
- 装运温度:Powder,RT